PendreaBio (also known as Keystone Nano) is a company that provides nanoscale solutions for the treatment of cancer. It develops NanoJackets (nanocolloids) and NanoLiposomes approaches to support the delivery of chemicals and pharmaceuticals. In addition to its expertise in designing, optimizing, and producing nanomaterials, the company can characterize these materials and test their efficacy in a range of in vitro and in vivo applications.